North Bergen, New Jersey 2/25/2010 5:30:35 AM
News / Business

FDA Approves Pfizers Latest Infection Vaccine

Wall Street Grand Reports the Latest News Regarding Pfizers recent Vaccine Approval

Pfizer Inc. (NYSE:PFE) engages in the discovery, development, manufacture, and marketing of prescription medicines for humans and animals worldwide. Its Pharmaceutical segment offers Lipitor for elevated cholesterol levels in the blood; Norvasc for hypertension; Caduet for cardiovascular events; Chantix/Champix for smoking cessation; Lyrica for neuropathic pain; Geodon/Zeldox, a psychotropic agent; and Aricept for Alzheimers disease. It also provides Celebrex for arthritis pain… Pfizer Inc. trades on the “New York Stock Exchange” under the Stock Symbol”PFE”. For the Latest information regarding “PFE”, make sure to visit the Most Exclusive and In Depth newsletter website at:   http://www.wallstreetgrand.com/.

 

Join today and be part of the best free investment newsletter on the web where we focus on market moving news.

 

Pfizer (NYSE:PFE) said on Wednesday that the Food and Drug Administration has approved an updated version of its best-selling infection vaccine for infants and children. Prevnar 13 is intended to reduce the risk of infection by 13 strains of pneumococcal disease in children 5 years old and younger. The disease causes ear infections, meningitis and pneumonia. Prevnar 13 adds protection against six additional strains of bacterial infection compared with the current vaccine. But that extra benefit comes with a price.

The new vaccine will cost $108 per dose, up 35 percent from $80. With four injections needed to complete the vaccine dosing, uninsured families would have to pay $432 out of pocket for Prevnar 13.

 

You can contact us during market hours at 1-888-9-ClubGrand (1888-925-8247) or via email at staff@wallstreetgrand.com .Gerard@WallStreetGrand.com

 

Safe Harbor

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act") including 2009 growth, revenue for the second quarter and year of 2009 and gross margin for the second quarter and year of 2009. Additionally, words such as "seek," "intend," "believe," "plan," "estimate," "expect," "anticipate" and other similar expressions are forward-looking statements within the meaning of the Act. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the impact of intense competition, the continuation or worsening of current economic conditions and the condition of the domestic and global credit and capital markets.

 

Disclaimer:

 

Wall Street Grand LLC has not been compensated by the company for this press release and does not expect to be compensated in the future for any type of awareness. To read our full disclaimer clicks the link http://www.wallstreetgrand.com/disclosure.html.